Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd Company History
Syncom Formulations India a renowned name in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur (30kms away from Indore, the commercial capital of Madhya Pradesh, India). Established in the year 1988, Syncom’s state of art WHO-GMP and ISO 9001-2015 certi?ed plant is geared up with latest production machineries and maintains high quality standards. Currently Syncom manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers.
1988
Syncom Formulation (India) Ltd. was established.
1988
2005
Company had allotted 2.65lakh fully paid-up equity shares of Rs 10 each at a premium of Rs 80 per share on the preferential basis.
2005
2006
Board of directors of the company had considered issue of 2.95 equity shares aggregating to Rs 1.59 crore on preferential basis.
The comapny approved an Rs 7.1 crore plan to install two wind mills of 0.60 MW each at Sangli in Maharashtra.
2006
2008
Board of directors of the company had approved amendment in the Articles of Association for insertion of clauses relating to authorizing the board for issuance of warrants convertible into equity shares of the company.
On 25th March 2008, board of directors of the company had transacted the allotment of 3.1 lakh equity shares of Rs 10 each by way of preferential allotment at a premium of Rs 36per equity share to Shri. Kedarmal Bankda, promoter of the company.
On the same date board of directors of the company had transacted the allotment of 3.25 lakh warrants of Rs 46 each.
2008
2009
Syncom Formulations India has recommended the dividend @ Rs. 0.50 (5%) on equity shares of Rs. 10/- each
Syncom Formulation (India) Ltd Issues Rights in the Ratio of 1:2
2009
2011
Mrs. Shikha Sethi, has been appointed as the Company secretary of the Company
2011
2012
Company has incorporated a Wholly Owned Subsidiary Company in the name of "TRADE ZONE FZE" in the United Arab Emirates
Shri. Praveen Jindal has been appointed as an Independent Director of the company.
2012
2013
The Company in the proportion of 5 (Five) Equity Shares of Rs. 1 (Rs. One) for every 2 (Two) Equity Shares of Rs. 1 (Rs. One) held by them on the record date as may be decided by the Board with the consultation of the Stock Exchange.
The Company has recommend a dividend Rs. 0.60 (Sixty paise) (6%) per equity share of Rs. 10/- each for the year 2012-13,
Syncom Formulation (India) has announces bonus in the ratio of 5:2
Syncom Formulation (India) has splits its face value from Rs 10/- to 1/-
2013
2014
The Company has recommend a dividend of Rs. 0.02 (Two paise) (2%) per equity share of Re. 1/- each for the year 2013-14
The Company has appointed Smt. Rinki Bankda in the category of Women Director as an Additional Director of the Company w.e.f. August 13, 2014.
2014
2022
Syncom Formulations (India) Limited has awarded 'PRODUCT EXCELLENCE 2022' under the category of 'Pharma (Medium)'organized.
2022
